thomthommm
2021-11-16
Yes yes yes
Pfizer, BioNTech, Moderna making $1,350 profit every second
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":871854869,"tweetId":"871854869","gmtCreate":1637055314374,"gmtModify":1637055314477,"author":{"id":3581655595250666,"idStr":"3581655595250666","authorId":3581655595250666,"authorIdStr":"3581655595250666","name":"thomthommm","avatar":"https://static.tigerbbs.com/0c38556c54b3cc7a747b7e281febac2a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Yes yes yes </p></body></html>","htmlText":"<html><head></head><body><p>Yes yes yes </p></body></html>","text":"Yes yes yes","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/871854869","repostId":2183005290,"repostType":4,"repost":{"id":"2183005290","kind":"news","pubTimestamp":1637043968,"share":"https://www.laohu8.com/m/news/2183005290?lang=&edition=full","pubTime":"2021-11-16 14:26","market":"us","language":"en","title":"Pfizer, BioNTech, Moderna making $1,350 profit every second","url":"https://stock-news.laohu8.com/highlight/detail?id=2183005290","media":"The Straits Times","summary":"WASHINGTON (AFP) - Pfizer, BioNTech and Moderna are making combined profits of US$65,000 (S$88,000) ","content":"<div>\n<p>WASHINGTON (AFP) - Pfizer, BioNTech and Moderna are making combined profits of US$65,000 (S$88,000) every minute from their highly successful Covid-19 vaccines while the world's poorest countries ...</p>\n\n<a href=\"http://www.straitstimes.com/world/pfizer-biontech-moderna-making-1350-profit-every-second\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, BioNTech, Moderna making $1,350 profit every second</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, BioNTech, Moderna making $1,350 profit every second\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-16 14:26 GMT+8 <a href=http://www.straitstimes.com/world/pfizer-biontech-moderna-making-1350-profit-every-second><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>WASHINGTON (AFP) - Pfizer, BioNTech and Moderna are making combined profits of US$65,000 (S$88,000) every minute from their highly successful Covid-19 vaccines while the world's poorest countries ...</p>\n\n<a href=\"http://www.straitstimes.com/world/pfizer-biontech-moderna-making-1350-profit-every-second\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","BNTX":"BioNTech SE","PFE":"辉瑞"},"source_url":"http://www.straitstimes.com/world/pfizer-biontech-moderna-making-1350-profit-every-second","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2183005290","content_text":"WASHINGTON (AFP) - Pfizer, BioNTech and Moderna are making combined profits of US$65,000 (S$88,000) every minute from their highly successful Covid-19 vaccines while the world's poorest countries remain largely unvaccinated, according to a new analysis.\nThe companies have sold the vast majority of their doses to rich countries, leaving low-income nations in the lurch, said the People's Vaccine Alliance (PVA), a coalition campaigning for wider access to Covid-19 vaccines, which based its calculations on the firms' own earning reports.\nThe Alliance estimates that the trio will make pre-tax profits of US$34 billion this year between them, which works out to over US$1,000 a second, US$65,000 a minute or US$93.5 million a day.\n\"It is obscene that just a few companies are making millions of dollars in profit every single hour, while just two percent of people in low-income countries have been fully vaccinated against coronavirus,\" Ms Maaza Seyoum of the African Alliance and People's Vaccine Alliance Africa said.\n\"Pfizer, BioNTech and Moderna have used their monopolies to prioritise the most profitable contracts with the richest governments, leaving low-income countries out in the cold.\"\nPfizer and BioNTech have delivered less than 1 per cent of their total supplies to low-income countries while Moderna has delivered just 0.2 per cent, the PVA said.\nCurrently, 98 per cent of people in low-income countries have not been fully vaccinated.\nThe three companies' actions are in contrast to AstraZeneca and Johnson & Johnson, which provided their vaccines on a not-for-profit basis, though both have announced they foresee ending this arrangement in future as the pandemic winds down.\nPVA said that despite receiving public funding of more than US$8 billion, Pfizer, BioNTech and Moderna have refused calls to transfer vaccine technology to producers in low- and middle-income countries via the World Health Organisation, \"a move that could increase global supply, drive down prices and save millions of lives\".\n\"In Moderna's case, this is despite explicit pressure from the White House and requests from the WHO that the company collaborate in and help accelerate its plan to replicate the Moderna vaccine for wider production at its mRNA hub in South Africa,\" the group said.\nWhile Pfizer CEO Albert Bourla has dismissed technology transfer as \"dangerous nonsense\", the WHO's decision to grant emergency use approval to the Indian-developed Covaxin earlier this month proves that developing countries have the capacity and expertise, PVA added.\nPVA, whose 80 members include the African Alliance, Global Justice Now, Oxfam, and UNAids, is calling for pharmaceutical corporations to immediately suspend intellectual property rights for Covid-19 vaccines by agreeing to a proposed waiver of World Trade Organisation's Trips agreement.\nMore than 100 nations, including the United States, back that move, but it is being blocked by rich countries including the UK and Germany.","news_type":1},"isVote":1,"tweetType":1,"viewCount":270,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":9,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/871854869"}
精彩评论